AnaptysBio Files 8-K
Ticker: ANAB · Form: 8-K · Filed: Mar 24, 2025 · CIK: 1370053
| Field | Detail |
|---|---|
| Company | Anaptysbio, Inc (ANAB) |
| Form Type | 8-K |
| Filed Date | Mar 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, sec-filing
Related Tickers: ANAB
TL;DR
ANAB filed an 8-K, standard reporting, no new info.
AI Summary
AnaptysBio, Inc. filed an 8-K on March 24, 2025, reporting other events and financial statements. The filing does not contain specific financial figures or material events beyond the standard reporting requirements.
Why It Matters
This filing indicates AnaptysBio is meeting its SEC reporting obligations, but provides no new material information for investors.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report and does not disclose any new material risks or events.
Key Players & Entities
- ANAPTYSBIO, INC (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- 10770 Wateridge Circle, Suite 210, San Diego, CA 92121 (address) — Principal Executive Offices
- 858-362-6295 (phone_number) — Registrant's Telephone Number
FAQ
What is the purpose of this 8-K filing for AnaptysBio?
This 8-K filing is for reporting 'Other Events' and 'Financial Statements and Exhibits' as of March 24, 2025.
Does this filing disclose any new financial results for AnaptysBio?
The filing indicates 'Financial Statements and Exhibits' are included, but does not provide specific financial figures or results within the provided text.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is March 24, 2025.
Where is AnaptysBio, Inc. headquartered?
AnaptysBio, Inc.'s principal executive offices are located at 10770 Wateridge Circle, Suite 210, San Diego, CA 92121.
What is the SEC file number for AnaptysBio?
The SEC file number for AnaptysBio is 001-37985.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 24, 2025 regarding ANAPTYSBIO, INC (ANAB).